Your strategic injectables CDMO for Asia’s evolving market
Asia’s biotech and pharmaceutical companies are rapidly emerging as global market leaders.
Asia’s biotech and pharmaceutical companies are rapidly emerging as global market leaders.
As a globally acting Contract Development and Manufacturing Organization (CDMO), Vetter is proud to partner these businesses in their efforts to advance their innovative new drug therapies. See how we can support you and your products at every step from early-stage clinical development to commercial manufacturing.
The future of the biopharmaceutical industry is taking shape in Asia. We’re already there to help you create it. In addition to our main regional branch in Singapore, Vetter has growing teams in Japan and Korea and additional offices opening soon in China.
For more than 40 years, Vetter has provided leading cGMP manufacturing services for worldwide partners of every size – from science-driven startups to global commercial-stage organizations. Today, we’re excited to form and grow new partnerships with Asia’s innovative biopharma enterprises. We look forward to supporting yours.